Ovid Therapeutics Inc.

NASDAQ:OVID

Biotechnology

Healthcare
$2.34 -4.34%

-$0.11 today

Market cap
$441.63M
Beta
0.18
P/E (TTM)
-7.1
EPS (TTM)
-$0.33
52W Low $0.29High $3.11

Volume 1.77M

Average 3.07M

Balance Sheet

Inspect the capital base behind the business.

Assets

$150.93M

FY 2025 · Annual

+63.8% YoY

Liabilities

$20.27M

FY 2025 · Annual

-15.3% YoY

Equity

$130.66M

FY 2025 · Annual

+91.5% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents187.8M44.87M27.04M26.3M13.15M
Short-term Investments084.13M78.79M26.77M56.48M
Net Receivables00000
Inventory00000
Other Current Assets2.68M11K020.81M
Total Current Assets190.48M131.38M109.6M55.94M90.45M
Property, Plant & Equipment (Net)242.76K16.07M14.66M13.23M0
Goodwill00000
Intangible Assets164K222.1K200K92K0
Long-term Investments3.56M5.62M17.63M20.97M64.7M
Tax Assets00000
Other Non-current Assets96.13K1.97M1.94M1.93M(4.22M)
Total Non-current Assets4.07M23.89M34.43M36.23M60.49M
Total Assets194.54M155.27M144.03M92.17M150.93M
Account Payables7.13M1.95M3.7M3.19M1.96M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities3.91M001K0
Total Current Liabilities14.8M6.99M11.47M10.52M8.29M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities0130M00
Total Non-current Liabilities016M44.76M13.42M11.99M
Total Liabilities14.8M22.99M56.23M23.94M20.27M
Common Stock70.36K70.47K71K71K130K
Retained Earnings(171.36M)(225.53M)(277.87M)(304.3M)(321.71M)
Accumulated OCI0(42.19K)0(35K)(202K)
Other Stockholders Equity0(1)0(0)0
Minority Interest00000
Total Equity179.75M132.27M87.8M68.23M130.66M
Total Debt016.54M16M14.76M13.42M
Net Debt(187.8M)(28.33M)(11.04M)(11.55M)266K

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$94.1M
Short-term Investments$61.5M
Other Current$4.6M
Total Current Assets$160.1M
PP&E (Net)$11.5M
Long-term Investments$42.0M
Other Non-current$12.0M
Total Non-current Assets$65.5M
Total Assets$225.6M

Analysis

Selected assets total $225.6M for Latest. The largest visible component is Cash & Equivalents at $94.1M, about 41.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
S-3S-3 filingNov 10, 2026
10-QQuarterly reportNov 10, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much cash does OVID have?

Ovid Therapeutics Inc. (OVID) reported $13.15M in cash and equivalents in fiscal 2025.

How much debt does OVID carry?

Ovid Therapeutics Inc. (OVID) reported $13.42M of total debt, with net debt of $266,000.00.